Key Points • We identified a high-risk subtype of NK cell–type CAEBV characterized by a high CpG island methylation pattern.• 5-Azacytidine is effective against this subtype of NK cell–type CAEBV in vitro and in vivo, suggesting it is a novel potential therapy.
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infection
Ryo Akazawa,Takashi Mikami,Masaki Yamada,I. Kato,Hirohito Kubota,S. Saida,Yoshinori Uchihara,Yuriko Ishikawa,T. Kamitori,Keiji Tasaka,Kiyotaka Isobe,Tomoya Isobe,K. Izawa,K. Umeda,H. Hiramatsu,Keita Jinnouchi,M. Hirata,Masakazu Fujimoto,T. Daifu,Hiroo Ueno,S. Nodomi,Machiko Sawada,Hisanori Fujino,K. Koh,M. Hiwatari,Motohiro Kato,Hiroaki Goto,I. Katano,Ryoji Ito,Mamoru Ito,N. Kakiuchi,M. Nakagawa,Y. Shiraishi,Y. Honda,Hiroyuki Yoshitomi,Hideki Ueno,Maho Sato,Satoru Miyano,Hironori Haga,Akihisa Sawada,K. Imadome,Seishi Ogawa,Junko Takita
Published 2025 in Blood
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Blood
- Publication date
2025-07-30
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-63 of 63 references · Page 1 of 1
CITED BY
Showing 1-4 of 4 citing papers · Page 1 of 1